Kate, the Princess of Wales, is marking one year since publicly announcing that her cancer is in remission, another milestone in her journey since revealing her cancer diagnosis two years ago. It was on Jan. 14, 2025, that Kate released a statement on social media, writing, "It is a relief to now be in remission and I remain focused on recovery."

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA offered an accelerated approval path.

Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal cancers. For example, survival rates for myeloma, a bone marrow cancer, jumped from 32% to 62%, liver cancer from 7% to 22% and lung cancer from 15% to 28%.

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 and 2021 — yet three specific types are still causing an alarming number

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, senior scientific director of surveillance research at

Only 183 patients referred for an urgent appointment with a breast cancer specialist were seen within 14 days between July and September 2025, according to latest figures from the Department of Health (DoH). That represents 3.5% patients who were referred for suspected breast cancer (5,309) across all five health and social care trusts.

The Supreme Court said Friday that it will decide whether tens of thousands of people claiming the pesticide Roundup caused their cancer will have a day in court, or whether a federal law that regulates pesticide labeling will effectively block their cases from moving forward.

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, physicians warn